Bradesco stock price today: BBD steadies near 52-week high after Brazil flags March rate cuts
29 January 2026
1 min read

Bradesco stock price today: BBD steadies near 52-week high after Brazil flags March rate cuts

New York, Jan 29, 2026, 09:24 EST — Premarket

  • Bradesco ADRs held steady just below a one-year peak ahead of the U.S. open.
  • Brazil’s central bank held the Selic rate at 15% but hinted that rate cuts could begin as soon as March.
  • Investors are eyeing fresh credit data alongside Bradesco’s upcoming quarterly results for signs of loan growth and defaults.

Banco Bradesco SA’s U.S.-listed shares (BBD) nudged 0.1% higher to $4.16 in premarket action Thursday, holding close to the upper end of their 52-week range following Wednesday’s close. 1

That modest move still carries weight. The bank’s shares have reflected changing bets on Brazil’s interest-rate trajectory, a crucial factor for loan demand and credit losses. On Wednesday, Brazil’s central bank held the Selic rate steady at 15%, its main policy benchmark, while signaling a likely start to cuts in March. Officials emphasized “serenity” regarding both the pace and magnitude of easing. Flavio Serrano, chief economist at Banco BMG, said policymakers were “as clear as possible” about the shift toward rate reductions and maintained his forecast for a 50-basis-point cut in March (a basis point equals 0.01 percentage point). 2

Official figures revealed that bank lending in Brazil climbed 10.2% in 2025, surpassing the central bank’s December forecast of 9.4%. The jump was driven by a pickup in household borrowing, supported by government credit stimulus programs. Total loans expanded 1.8% in December, reaching 7.1 trillion reais ($1.37 trillion). At the same time, a broad measure of defaults inched up to 5.4%, while lending spreads tightened slightly, the data showed. 3

Bradesco and its peers face a tricky balance: high rates boost interest income in some areas but strain borrowers, risking more problem loans. A genuine move toward rate cuts might spur credit demand, yet it could also tighten margins as the cycle shifts.

Some investors interpret the central bank’s tone as a signal for a sustained rally in Brazil-linked financials following a prolonged period of tight policy. Others remain cautious, seeing “serenity” as the statement’s main driver—a subtle warning that inflation hiccups could delay progress.

Other Brazil bank ADRs showed gains in early trading, with Itau Unibanco (ITUB) rising roughly 1.1% and Santander Brasil (BSBR) climbing about 1.4%.

There’s a clear risk, though. Should inflation pick up again or growth prove more resilient than policymakers expect, the central bank might tighten at a slower pace than markets anticipate. That would push rates higher for a longer stretch, increasing default risks—a particular headache for lenders heavily exposed to retail.

Bradesco’s next major event is its fourth-quarter earnings report. The bank’s quiet period lasts until Feb. 5, with results set to drop after markets close in Brazil and New York. A webcast will follow the next day, Feb. 6. 4

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Intel stock price slips after report-driven rally; Nvidia-Apple foundry chatter keeps INTC in focus
Previous Story

Intel stock price slips after report-driven rally; Nvidia-Apple foundry chatter keeps INTC in focus

Meta stock jumps about 9% as Zuckerberg bets big on “superintelligence” spending
Next Story

Meta stock jumps about 9% as Zuckerberg bets big on “superintelligence” spending

Go toTop